Navigation Links
CIGNA and Cancer Treatment Centers of America Reach New Agreement
Date:5/13/2010

Recognizing the importance of access, quality and choice for its many customers who have been touched by cancer, CIGNA expands access to all Cancer Treatment Centers of America physicians and facilities.

Chicago, IL (PRWEB) May 13, 2010 -- Recognizing the importance of access, quality and choice for its many customers who have been touched by cancer, CIGNA has entered into a new agreement that opens the doors to comprehensive, integrative care at Cancer Treatment Centers of America (CTCA).

The new agreement, effective recently, provides millions of CIGNA customers nationwide with in-network access to more than 330 physicians across CTCA’s four affiliated cancer treatment facilities. CTCA serves patients with advanced cancer at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix.

“Medical decisions are some of the most important decisions we make in our lives,” said Quintin Baytop of Baltimore, Md., a CIGNA customer who is receiving treatment at CTCA. “This is a welcome choice for cancer patients. We need increased access to quality cancer care and more options when it comes to choosing a hospital that is right for each of us.”

The agreement aligns with CIGNA’s longstanding commitment as a champion for consumer choice and high-quality, comprehensive care for its customers.

“Cancer affects a growing population, and we are dedicated to empowering cancer patients and their families with increased choice and access to affordable, quality health care,” said Sue Podbielski, President, CIGNA HealthCare Midwest Markets. “The addition of CTCA to our national network gives CIGNA customers access to a model of care that focuses on the individual needs of cancer patients and improving their quality of life.”

About Cancer Treatment Centers of America
Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. For more information about Cancer Treatment Centers of America, visit www.cancercenter.com.

About CIGNA
CIGNA (NYSE:CI), a global health service company, is dedicated to helping people improve their health, well being and sense of security. CIGNA Corporation's operating subsidiaries provide an integrated suite of medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance, to approximately 46 million people throughout the United States and around the world. To learn more about CIGNA, visit www.cigna.com. To sign up for email alerts or an RSS feed of company news, log on to http://newsroom.cigna.com/rss/. Also, follow us on Twitter: @cigna and visit CIGNA’s YouTube channel at http://www.youtube.com/cignatv.

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4001464.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Stellaris Health Network Hospitals Reach New Agreement with CIGNA HealthCare
2. Can Celebrex prevent cancer-causing colon polyps?
3. Study identifies 1 of the mechanisms behind breast cancer metastasis
4. NYU College of Dentistry, Penn State develop new model for investigating tobacco/oral cancer link
5. New hope for better treatment for a rising cancer
6. Small Changes in Two Genes May Trigger Breast Cancer
7. DCA research on brain cancer
8. New technology aids in prostate cancer treatment
9. StopYourDrip.com Announces the Launch of a New Exercise Program to Improve Male Urinary Incontinence After Prostate Cancer Surgery
10. Monitoring and control can limit side effects of promising cancer drugs
11. Exploring gender differences in colorectal cancer screenings
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CIGNA and Cancer Treatment Centers of America Reach New Agreement  
(Date:2/19/2017)... ... February 19, 2017 , ... ProBrand Glitch is a set of 30 glitch distortion ... users can easily reveal any logo with a glitch reveal in just a few clicks ... the style and animation of each preset. Use these presets to add a uniquely animated ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, not traditional ... industry, according to the recent NEJM Catalyst Insights Report on the New Marketplace. ... Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, and clinicians ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for ... so many other applications. Users can pick and choose from hand-crafted trend-setting ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance ... change designed to further positively impact the health and wellness of our community ... considered it our duty to seriously consider releasing our assets beyond our 5% ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 2017 Theravance Biopharma, Inc. (NASDAQ: ... today announced the presentation of positive clinical data ... pan-Janus kinase (JAK) inhibitor designed to be intestinally ... the European Crohn,s and Colitis Organization (ECCO). In ... from its completed Phase 1 study of single-ascending ...
(Date:2/17/2017)... , Feb. 17, 2017  In partnership with ... Friends for Good Health , The Jack Brewer ... filled with millions of dollars, worth of medicine to ... Haiti . IHI is a non-profit dedicated to treating ... is extremely active in Haiti ...
(Date:2/17/2017)...  Noble Capital Markets announced today that it has ... EPIX ). The report was issued by Noble,s ... ESSA Pharmaceuticals is a clinical stage biopharmaceutical ... Its lead compound EPI-506, is a small molecule oral ... androgen receptor, thereby has potential to overcome some of ...
Breaking Medicine Technology: